HN might inhibit neurodegeneration caused by polyQ diseases, such as dentatorubral-pallidoluysian atrophy (DRPLA), through the suppression of ASK1 and preventing the formation of polyQ aggregates (Kariya et al., 2005). The gene discussed is MAP3K5; the disease is dentatorubral-pallidoluysian atrophy.